BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aurobindo Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524804
ISIN Demat
INE406A01037
Book Value (Rs)
369.1611632
NSE Symbol
AUROPHARMA
Divident Yield %
0
Market Cap
(Rs In Cr.)
76,303
P/E (TTM)
35.59
EPS (TTM)
36.91
Face Value
(Rs)
1
Back
Aurobindo Pharma consolidated net profit rises 7.62% in the December 2025 quarter
14-Feb-26   Hrs IST

Net profit of Aurobindo Pharma rose 7.62% to Rs 910.29 crore in the quarter ended December 2025 as against Rs 845.81 crore during the previous quarter ended December 2024. Sales rose 9.01% to Rs 8604.51 crore in the quarter ended December 2025 as against Rs 7893.15 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales8604.517893.15 9
OPM %20.6119.99 -
PBDT1868.581618.38 15
PBT1403.851199.85 17
NP910.29845.81 8

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)